In addition, transcription factor AP2-β also activates the CK1/GSK3β-mediated phosphorylation-dependent proteasomal degradation of β-catenin by binding to β-catenin and β-TrCP, leading to the suppression of cervical cancer cell proliferation [180]. The gene discussed is TFAP2B; the disease is cervical carcinoma.